IDE Reports: Suggested Format for IDE Final Report
- Basic Elements
- IDE Number
- Device name and indication for use
- Sponsor's name, address, phone number, and fax number
- Contact person
- Study Progress. Data from beginning of the study should be reported, unless otherwise indicated.
- Brief summary of study progress in relation to investigational plan
- Number of investigators/investigational sites (attach list of investigators)
- Number of subjects enrolled (by indication or model)
- Number of devices shipped
- Disposition of all devices shipped
- Brief summary of results
- Summary of anticipated and unanticipated adverse effects
- Description of any deviations from the investigational plan by investigators (since last progress report)
- Risk Analysis
- Summary of any new adverse information (since last progress report) that may affect the risk analysis; this includes preclinical data, animal studies, foreign data, clinical studies, etc.
- Reprints of any articles published from data collected from this study
- Other Changes
- Summary of any changes in manufacturing practices and quality control (including changes not reported in a supplemental application)
- Summary of all changes in investigational plan not required to be submitted in a supplemental application
- Marketing Application or Future Plans
- Progress toward product approval, with date (or projected date) of PMA or 510(k) submission; or indication that marketing of device is not planned.
- Any plans to submit another IDE application for this device or a modification of this device.
Featured Products
ISO 13485 Internal Auditor Checklist
Price: $95.00
Price: $95.00
Best Practices for Maintaining an IND and IDE Application with FDA
IND and IDE annual reports - Amending clinical protocols and informed consent – Format, Content, Editing, Submission of Documents
IND and IDE annual reports - Amending clinical protocols and informed consent – Format, Content, Editing, Submission of Documents
IDE (Investigational Device Exemption) for PMA and 510(k) for CDRH and CBER
Meetings with FDA - Sample Size Considerations - Inclusion/Exclusion Criteria - End Points - Case Report Forms - Administrative Plan
Meetings with FDA - Sample Size Considerations - Inclusion/Exclusion Criteria - End Points - Case Report Forms - Administrative Plan
The IDE (Investigational Device Exemption) - It's Purpose and Preparation
The purpose of the IDE – FDA Expectations – preparation – recommended subject headings – content submission - follow up Usage in the clinical trial
The purpose of the IDE – FDA Expectations – preparation – recommended subject headings – content submission - follow up Usage in the clinical trial
Planning for a Successful Pre-IDE Meeting with FDA
Pre-IDE Meeting – Process- Submission preparation - presentation
Pre-IDE Meeting – Process- Submission preparation - presentation